Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27299573 | 1.00 | DNM1 (0.36) | DNM1TSHRALDH1A1CYP3A4SLC2A1 | |
| SCHEMBL5358878 | 0.95 | DNM1 (0.39) | DNM1TSHRALDH1A1CYP3A4SLC2A1 | |
| SCHEMBL22602 | 0.90 | LMNA (0.39) | DNM1TSHRFDPSEPHX1LMNA | |
| SCHEMBL5359912 | 0.89 | SLC6A4 (0.32) | TSHRSIGMAR1 | |
| Hydrochloric Acid SCHEMBL28410950 | 0.88 | LMNA (0.38) | DNM1TSHRFDPSEPHX1LMNA | |
| SCHEMBL24870689 | 0.87 | DNM1 (0.46) | DNM1TSHRPLA2G2CCA2FDPS | |
| SCHEMBL16649197 | 0.86 | OPRM1 (0.42) | DNM1TSHRALDH1A1FDPSEPHX1 | |
| SCHEMBL9852681 | 0.84 | LMNA (0.42) | DNM1TSHRFDPSEPHX1LMNA | |
| SCHEMBL6900932 | 0.84 | LMNA (0.42) | DNM1TSHRFDPSEPHX1LMNA | |
| SCHEMBL2328457 | 0.84 | LMNA (0.42) | DNM1TSHRFDPSEPHX1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091707-A1 | BICYCLIC INHIBITORS OF JAK AND METHODS OF USE | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-05-25 | — | — | WO | disclosed |
| US-10564980-B2 | Apparatus, methods, and systems for conditional queues in a configurable spatial accelerator | INTEL CORPORATION (US) | 2020-02-18 | — | — | US | disclosed |
| US-20190303168-A1 | APPARATUS, METHODS, AND SYSTEMS FOR CONDITIONAL QUEUES IN A CONFIGURABLE SPATIAL ACCELERATOR | INTEL CORPORATION | 2019-10-03 | — | — | US | disclosed |
| EP-1290002-A1 | CHEMICAL PRODUCTS SUITED FOR USE AS CO-CATALYSTS, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | Basell Polyolefine GmbH (DE) | 2003-03-12 | — | — | EP | disclosed |
| EP-1280600-A2 | SUPPORTED CATALYST SYSTEM COMPRISING A METALLOCENE, A LEWIS-BASE AND AN ORGANODEMENTAL COMPOUND OF MAIN GROUP III, AND ITS USE | Basell Polypropylen GmbH (DE) | 2003-02-05 | — | — | EP | disclosed |
| WO-2001090112-A1 | CHEMICAL PRODUCTS SUITED FOR USE AS CO-CATALYSTS, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2001-11-29 | — | — | WO | disclosed |
| WO-2001047635-A2 | SUPPORTED CATALYST SYSTEM CONTAINING A METALLOCENE, A LEWIS BASE AND AN ELEMENTALLY ORGANIC COMPOUND OF MAIN GROUP III AND THE USE THEREOF | BASELL POLYPROPYLEN GMBH (DE) | 2001-07-05 | — | — | WO | disclosed |